Absence of ATM leads to altered NK cell function in mice

Daniela Angela Covino1, Maria Giovanna Desimio1, Alessandro Giovinazzo2

  • 1Research Unit of Primary Immunodeficiencies, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Insights

Ataxia-telangiectasia (A-T) impairs natural killer (NK) cell tumor killing due to signaling defects. However, NK cell function can be enhanced in A-T mice with lymphoma, suggesting potential therapeutic avenues.

Area of Science:

  • Immunology
  • Genetics
  • Oncology

Background:

  • Ataxia-telangiectasia (A-T) is a rare genetic disorder caused by mutations in the ATM kinase gene.
  • A-T is characterized by neurodegeneration, immunodeficiency, and an increased risk of cancer.
  • The role of natural killer (NK) cells in A-T-associated immunodeficiency and cancer is not fully understood.

Purpose of the Study:

  • To investigate the function of NK cells in a mouse model of Ataxia-telangiectasia (Atm-/-).
  • To explore the impact of A-T on NK cell-mediated tumor cell killing and the underlying molecular mechanisms.
  • To identify potential biomarkers and therapeutic targets related to NK cell biology in A-T.

Main Methods:

  • Utilized Atm-/- mice as a model for Ataxia-telangiectasia.
  • Assessed NK cell cytotoxicity against tumor cells in Atm-/- mice.
  • Analyzed NK cell signaling pathways and the expression of NKG2D ligands (e.g., MULT1).

Main Results:

  • NK cells from Atm-/- mice exhibit impaired tumor cell killing due to blocked early signaling events.
  • In Atm-/- mice with thymic lymphoma, NK cell cytotoxicity is enhanced, potentially mediated by tumor-derived TNF-α.
  • Expansion of exhausted NKG2D+ NK cells in Atm-/- mice is linked to low-level NKG2D ligand expression, while thymoma development correlates with NKG2D down-regulation.

Conclusions:

  • Genetic defects in ATM kinase significantly impact NK cell function in Ataxia-telangiectasia.
  • NK cell dysfunction in A-T contributes to immunodeficiency and cancer susceptibility.
  • Further research into NK cell biology in A-T patients may reveal predictive biomarkers and novel therapeutic strategies for cancer treatment.